Previous Episodes 11 – 20
Bob and Eric sit down with Media Relations Director of the National Cannabis Industry Association, Morgan Fox to discuss the progress being made in cannabis policy in D.C. and around the country, the uncertainty posed by an election year, shifting rhetoric from democratic candidates over the last few election cycles, and whether or not coronavirus will accelerate cannabis reform or put in on the backburner.
Bob and Eric sit down with Managing Attorney of Hoban Law Group, Garrett Graff to discuss what cannabusiness owners need to be thinking about as it relates to legal considerations including contracts, force majeure clauses, liability, whether the COVID-19 pandemic qualifies as an “Act of God,” and much more.
Bob and Eric sit down with VP of Strategic Development for International Hemp Solutions, Tom Dermody to discuss the significance of cannabis businesses to be deemed as essential services in the States of Colorado, California, and Washington in the wake of shelter in place bans spurred by local, state, and federal government officials’s efforts to reduce the spread of COVID-19.
Bob and Eric sit down with CEO of Hemp Point, Hana Gabrielová who shares her perspective on how the Czech Republic has been impacted by COVID-19 in recent weeks. They discuss the global market for hemp seeds originating from European plant breeders, the difference between farming hemp for fiber and growing hemp for cannabinoids, and the shifting attitude toward hemp in American agriculture.
Bob and Eric sit down with Hoban Law Group Senior Attorney, Steve Schain to discuss the obstacles standing in the way of banking for hemp and marijuana businesses, what the future holds for the SAFE Banking Act, and the motto of the Post-Coronavirus economy: “Cash is King.”
Bob and Eric sit down with Founder of the Last Prisoner Project, Steve DeAngelo to discuss the challenges facing the legal marijuana industry in California, shifting paradigms and global perspectives on cannabis, and the valuable work of the Last Prisoner Project, the need of which has been greatly accelerated by the Coronavirus pandemic.
Bob and Eric sit down with Prohibition Partners’ Head of Insights, Alexandra Curley who shares her perspective on how Ireland has been impacted by the spread of COVID-19. They discuss how consumers may drive increased sales for CBD products post-Coronavirus, the complexity, and patchwork of regulations across the European Union, and insights from the valuable global cannabis data and analytics work advanced by Prohibition Partners.
Bob and Eric sit down with Former Managing Director of Phyto Partners, Brett Finkelstein to discuss whether or not this economic downturn will accelerate consolidation in the cannabis industry, the history of North American cannabis investment, and what investors look for in a cannabusinesses portfolio.
Bob and Eric sit down with Founder and CEO of Global Health and Hygiene Solutions, Occupational and Environmental Medicine physician, Dr. Uma to discuss the critical importance of spreading education on the endocannabinoid system, the five things every person should know about their body, and how to take preventative health precautions to prepare for a future pandemic.
Bob and Eric sit down with Founder and CEO of 3C Consulting, Nic Easley to discuss the health of the cannabis industry before the recent market downturn, the difference between an industry being recession-proof and depression-proof, immediate actions business owners and companies need to be taking during this pandemic, and what 2020 may hold in store for hemp farmers.